PedAM
Pediatric Disease Annotations & Medicines
| Disease | pleural effusion disorder |
| Symptom | |lung cancer |
| Sentences | 63 |
| PubMedID- 24851110 | lung cancer patients suspected of having a pleural effusion undergo a chest x-ray and contrast-enhanced computed tomography to confirm the presence of fluid in the pleural cavity and to evaluate the pleura for nodularity or thickening, which may suggest metastasis 4. |
| PubMedID- 23925664 | Vascular endothelial growth factor (vegf) is involved in non-small cell lung cancer (nsclc) with malignant pleural effusion (mpe), but little is known regarding the efficacy of bevacizumab (bev) with carboplatin-paclitaxel (cp) for nsclc with mpe. |
| PubMedID- 21108775 | She had been suffering from lung cancer with pleural effusion for five years. |
| PubMedID- 23688054 | Prognostic values of vegf and il-8 in malignant pleural effusion in patients with lung cancer. |
| PubMedID- 25699082 | A thoracoscopic biopsy of the pleura had the highest yield for diagnosing metastatic pleural effusion in a patient with lung cancer. |
| PubMedID- 23681012 | In pleural effusion from patients with lung cancer, the level of mir-198 was also decreased. |
| PubMedID- 23364973 | This study aimed to evaluate the diagnostic and prognostic value of pleural crp (p-crp) in lung cancer patients with malignant pleural effusion (mpe). |
| PubMedID- 20093263 | Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination. |
| PubMedID- 23964349 | A preparation containing these proteins was recently used to treat advanced lung cancer with pleural effusion. |
| PubMedID- 20207133 | A phase i clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. |
| PubMedID- 22461838 | Moreover, the definition of earlier diagnosis of pleural effusions of patients with lung cancer by means of detecting tumor marker mrna in occult lung cancer cells had previously been reported in our studies . |
| PubMedID- 25750307 | Predominance of th17 over regulatory t-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile. |
| PubMedID- 25207893 | Conclusion: high clinical efficacy of elemene was found in the treatment malignant pleural effusion in patients with lung cancer. |
| PubMedID- 24348666 | Sasaki et al.52 reported that cells derived from pleural effusions of patients with eml4-alk lung cancer who developed acquired resistance to crizotinib displayed the gatekeeper l1196m mutation and high levels of expression of egfr ligands (egf and amphiregulin). |
| PubMedID- 26301886 | Evaluation of serum and pleural levels of soluble b7-h4 in lung cancer patients with pleural effusion. |
| PubMedID- 23088463 | Clinical significance of cyfra21-1, scc-ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer. |
| PubMedID- 22431315 | The aim of this study was to evaluate the individual and combined diagnostic utility of vascular endothelial growth factor (vegf) mrna and endostatin mrna in pleural effusions of patients with lung cancer. |
| PubMedID- 26034319 | Aetiologies of pleural effusion included lung cancer (n = 14), tuberculosis (n = 9), breast cancer (n = 7), ovarian cancer (n = 2), malignant mesothelioma (n = 1), congestive cardiac failure (n = 1), peritoneal dialysis (n = 1) and hepatic hydrothorax (n = 1); pleural effusion was undiagnosed in five patients. |
| PubMedID- 25935866 | Thirty tpe patients and 20 lung cancer patients with malignant pleural effusion (mpe) were recruited. |
| PubMedID- 25999646 | Patients in this study are enrolled in a phase i clinical trial of hpph-mediated pdt for the treatment of non-small cell lung cancer with pleural effusion. |
| PubMedID- 24223764 | Moreover, t regulatory cells inhibit generation and differentiation of th17 cells in malignant pleural effusion of patients with lung cancer . |
| PubMedID- 24049303 | Reporting a case, 53 years old male with stage iv nonsamall cell lung cancer in view of cytologically proven malignant pleural effusion. |
| PubMedID- 24913066 | Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion. |
| PubMedID- 24072496 | Interleukin 17 (il-17) has been found to be increased in some human cancers; however, the possible implication of il-17 in regulating antitumor responses in lung cancer patients with malignant pleural effusions (mpe) remains to be elucidated. |
| PubMedID- 22875282 | A lectin microarray, ltl, psa, lca, uea-1, aal, mal-i, mal-ii, sna, wga, ecl, dsa, stl, swga, hpa, cona, gna, hhl, bpl, eel, jacalin, wfa, acl, mpl, dba, sba, was used to determine the glycoprotein profile of cells in pleural effusions from patients with lung cancer (54 cases), and with benign lung disease (54 cases). |
| PubMedID- 24383440 | Another rare isolate, from puncture fluid of a lung cancer patient with pleural effusion, bilophila wadsworthia, is a unique gram-negative anaerobic rod bacterium that has not been reported in mainland china but in taiwan . |
| PubMedID- 23178954 | Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion. |
| PubMedID- 24086497 | lung cancer patients with malignant pleural effusion (mpe) have inferior prognosis, therefore, this group of patients are reclassified as early metastasis (m1a)-stage 4 instead of stage 3b according to the current american joint committee on cancer (ajcc) staging guidelines. |
| PubMedID- 22464057 | Htert gene amplification and clinical significance in pleural effusions of patients with lung cancer. |
| PubMedID- 23164351 | Clinical role of f-18 fdg pet/ct in differentiating malignant and benign pleural effusion in patients with lung cancer. |
| PubMedID- 23649436 | Thoracoscopic biopsy of the pleura has the highest diagnostic yield for diagnosis of metastatic pleural effusion in a patient with lung cancer. |
| PubMedID- 22966327 | Concerning the lysate of sediment, cea was high in the pleural effusions of patients with lung cancer and ca15-3 in those of patients with breast cancer. |
| PubMedID- 26323029 | Purpose to determine the frequency and investigate possible mechanisms and prognostic relevance of minimal (<10-mm thickness) pleural effusion in patients with small cell lung cancer (sclc). |
| PubMedID- 25800577 | It has the characteristics of inhibiting trypsin and high expression in the serum or malignant pleural effusion of patients with lung cancer. |
| PubMedID- 22363829 | In contrast, the pulmonary edema developed on day 16 in patients 4 who had an underlying lung cancer with malignant pleural effusion obviously resulted from fluid overload. |
| PubMedID- 22744209 | After testing a protocol for ad.cd transfer and lung tumor burden control in a lewis mouse model, we used this technique in the management of lung cancer patients with malignant pleural effusion (mpe): two cases are presented investigating the possible enhancement of anticancer effect in both non-small-cell lung cancer (nsclc) and small-cell lung cancer (sclc) by local activation of the pro-drug 5-fc. |
| PubMedID- 20819493 | Objective: to compare the therapeutic effects of pleural perfusion of ndp and cddp in non-small cell lung cancer (nsclc) patients with malignant pleural effusion, their quality of life and toxic side effects. |
| PubMedID- 26508030 | Hpv16, hif-1alpha, and glut1 were detected in pleural effusions of patients with lung cancer (n = 95) and with benign lung disease (n = 55) by immunocytochemistry. |
| PubMedID- 23217146 | Th17 cells accumulate in malignant pleural effusion from patients with lung cancer . |
| PubMedID- 23243596 | The first one (nct00690261; current status: recruiting) specifically aims at investigating impact of m1/m2 macrophage polarization on cancer progression and prognosis prediction among lung cancer patients with malignant pleural effusions. |
| PubMedID- 23523589 | Background: apolipoprotein e (apoe) levels have been shown to be elevated in pleural effusion of patients with non-small cell lung cancer (nsclc). |
| PubMedID- 20673505 | It can further improve the accuracy for the diagnosis of lung cancer with pleural effusion. |
| PubMedID- 20676675 | It was also reported that pdgf levels of pleural effusion with lung cancer were higher than in non-malignant pleural effusions . |
| PubMedID- 26134225 | Introduction: a subset of non-small-cell lung cancer (nsclc) patients with malignant pleural effusion and/or malignant pleural nodules is now classified as stage iv and is generally considered a contraindication to surgery. |
| PubMedID- 22305792 | Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion. |
| PubMedID- 22584211 | pleural effusion in lung cancer: more questions than answers. |
| PubMedID- 21552017 | Impact of dual-time-point f-18 fdg pet/ct in the assessment of pleural effusion in patients with non-small-cell lung cancer. |
| PubMedID- 24758329 | Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer. |
| PubMedID- 26005243 | The patients studied here are enrolled in a phase i clinical trial of hpph-mediated pdt for the treatment of non-small cell lung cancer with pleural effusion. |
| PubMedID- 23759037 | According to the national comprehensive cancer network (nccn) clinical practice guidelines in oncology , most pleural effusions associated with lung cancer should appear in stage iv. |
Page: 1 2